This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
Take the Zacks Approach to Beat the Markets: Amneal Pharmaceuticals, Leidos & Vishay Precision in Focus
by Santanu Roy
Amneal Pharmaceuticals, Leidos and Vishay Precision stand out as Zacks highlights amid market volatility and shifting rate expectations.
GSNegative Net Change JNJNegative Net Change HSYNegative Net Change HDPositive Net Change AZONegative Net Change VPGNegative Net Change LDOSNegative Net Change SHOPPositive Net Change NOBLPositive Net Change NTLAPositive Net Change AMRXPositive Net Change HIPONegative Net Change
computers consumer-staples finance insurance medical pharmaceuticals retail
How to Play HOLX Stock This Breast Cancer Awareness Month?
by Moumi Mondal
Hologic's breast health innovations, AI breakthroughs and leadership moves signal optimism ahead despite macro headwinds.
HOLXNegative Net Change QGENPositive Net Change GEHCNegative Net Change
medical medical-devices
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
by Zacks Equity Research
ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.
MASINegative Net Change AXGNNegative Net Change PAHCPositive Net Change CLPTNegative Net Change
medical medical-devices
BRKR Shares Climb After Securing New Orders for Its NMR Systems
by Zacks Equity Research
Bruker stock climbs after securing $10M in federally funded NMR orders from top U.S. research institutions.
BSXPositive Net Change MASINegative Net Change BRKRPositive Net Change PAHCPositive Net Change
medical
New Strong Sell Stocks for October 6th
by Zacks Equity Research
ACHC, ALSN and BSM have been added to the Zacks Rank #5 (Strong Sell) List on October 6, 2025.
ALSNNegative Net Change ACHCNegative Net Change BSMPositive Net Change
medical
Top Stock Reports for AMD, Abbott & Micron Technology
by Mark Vickery
AMD, Abbott and Micron shine in fresh Zacks reports, highlighting AI momentum, product pipelines and strong financial positioning.
ABTNegative Net Change AMDPositive Net Change COPPositive Net Change MUNegative Net Change SMCIPositive Net Change INSMNegative Net Change
computers finance medical
Hims & Hers Expands Health Access Through Subscription Revenue Model
by Zacks Equity Research
HIMS boosts predictable revenue and customer loyalty with a flexible, subscription-based model across key health categories.
MEDNegative Net Change AMWLPositive Net Change HIMSPositive Net Change
medical medical-devices
ILMN Stock Set to Benefit From the Launch of New BioInsight Division
by Zacks Equity Research
Illumina launches BioInsight to harness multiomic data, accelerate drug discovery, and boost disease diagnosis.
ILMNPositive Net Change MASINegative Net Change PAHCPositive Net Change CRMDNegative Net Change
medical medical-devices
Is the Options Market Predicting a Spike in Masimo Stock?
by Zacks Equity Research
Investors need to pay close attention to MASI stock based on the movements in the options market lately.
MASINegative Net Change
medical
Are Options Traders Betting on a Big Move in Septerna Stock?
by Zacks Equity Research
Investors need to pay close attention to SEPN stock based on the movements in the options market lately.
SEPNNegative Net Change
medical
Trump's CBD Video Sparks Buzz: 3 Cannabis Stocks to Watch
by Sundeep Ganoria
Trump's CBD video fuels momentum in cannabis, with Village Farms, Canopy Growth, and Tilray emerging as stocks to watch in 2025.
CGCPositive Net Change TLRYPositive Net Change VFFPositive Net Change
marijuana medical
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves
by Zacks Equity Research
AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains; it also raises FY26 sales outlook, sending shares higher.
ANGONegative Net Change MASINegative Net Change PAHCPositive Net Change CRMDNegative Net Change
earnings medical medical-devices
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
by Zacks Equity Research
Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.
BSXPositive Net Change HOLXNegative Net Change MASINegative Net Change PAHCPositive Net Change
medical
From Apps to Nutrition: Health & Fitness Stocks to Buy Now
by Nilanjan Choudhury
UNFI, AMWL, STKL, and PTON stand out as health and fitness plays, tapping into booming demand for wellness, nutrition and digital care.
AMZNPositive Net Change AAPLNegative Net Change STKLNegative Net Change UNFINegative Net Change PTONPositive Net Change AMWLPositive Net Change
consumer-discretionary consumer-staples medical
New Strong Buy Stocks for October 3rd
by Zacks Equity Research
DORM, AEG, GMAB, SCSC and GFI have been added to the Zacks Rank #1 (Strong Buy) List on October 3rd, 2025.
AEGNegative Net Change GFINegative Net Change SCSCPositive Net Change DORMNegative Net Change GMABNegative Net Change
auto-tires-trucks gold industrial-products insurance medical
Top Research Reports for Boston Scientific, Union Pacific & Realty Income
by Mark Vickery
Boston Scientific gains from MedSurg and cardiovascular strength, while Union Pacific and Realty Income face mixed headwinds.
BSXPositive Net Change UNPPositive Net Change ADMNegative Net Change DDPositive Net Change OPositive Net Change TDYPositive Net Change WEYSNegative Net Change
consumer-discretionary medical reit transportation
Can Novo Nordisk's Restructuring Program Drive its Return to Growth?
by Ahan Chakraborty
NVO is cutting 9,000 jobs, targeting DKK 8 billion in savings, and shifting focus to obesity and diabetes R&D to regain growth momentum.
BMYPositive Net Change NVONegative Net Change MRKNegative Net Change
biotechnology biotechs medical pharmaceuticals
Natural Alternatives Q4 Sales Rise 15% Y/Y, Loss Widens for FY25
by Zacks Equity Research
NAII sales rise y/y in the fourth quarter of fiscal 2025, but higher charges and underused capacity widen loss.
NAIINegative Net Change
earnings medical
Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency?
by Sundeep Ganoria
Moderna plans up to 10 product launches over four years, aiming to cut reliance on fading COVID-19 vaccine sales.
PFEPositive Net Change MRKNegative Net Change MRNANegative Net Change BNTXNegative Net Change
biotechs medical pharmaceuticals
Humana Benefits From Rising Premiums Amid High Benefit Ratio
by Zacks Equity Research
HUM gains from rising premiums, Medicare growth and CenterWell expansion, but faces pressure from high benefit ratios and costs.
HUMNegative Net Change CINegative Net Change ELVNegative Net Change
medical
ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7
by Zacks Equity Research
Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.
SYKNegative Net Change OFIXNegative Net Change GMEDNegative Net Change ZBHPositive Net Change
medical
Stock Market News for Oct 2, 2025
by Zacks Equity Research
Wall Street closed higher on Wednesday, driven by healthcare stocks.
ADPNegative Net Change AMGNPositive Net Change ABBVNegative Net Change
business-services medical
Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker
by Zacks Equity Research
ILMN partners with pharma leaders to advance KRAS-focused companion diagnostics through its TruSight Oncology platform.
TMOPositive Net Change ILMNPositive Net Change MYGNPositive Net Change QGENPositive Net Change
medical medical-devices
Can Doximity's New AI Suite Drive the Growth It Needs?
by Indrajit Bandyopadhyay
DOCS reports stronger Q1 results and is betting on its new AI suite -- Scribe, GPT, and Pathway -- to drive its next growth phase.
CERTPositive Net Change DOCSPositive Net Change GEHCNegative Net Change
medical medical-devices
Nyxoah Expands in the Middle East to Provide Wider Access to Genio
by Zacks Equity Research
NYXH expands in the Middle East after Abu Dhabi's first Genio implant, aiming to broaden access for OSA patients.
RMDNegative Net Change LIVNNegative Net Change INSPNegative Net Change NYXHPositive Net Change
medical medical-devices